Health
NHS set to pilot GRAIL’s wide-ranging cancer blood test – PMLiVE
Previous study indicates test can detect over 50 cancer types
The UK’s National Health Service (NHS) has signed a deal with healthcare company GRAIL to pilot its novel cancer blood test in 165,000 patients.
The Galleri blood test will be offered to 165,000 patients by NHS England in a new programme aimed at detecting early stage cancers.
The blood test identifies signs of a range of cancer types by searching for small fragments of DNA and RNA from tumours in the bloodstream to determine the presence of cancer.
The NHS will identify programme participants…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News21 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News22 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News15 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track